Shares of Tel Aviv-based InspireMD plunged 30% during morning trade after the company priced its public offering of 486,957 common stock at $5 apiece. The company, which makes Carotid Embolic Prevention System, expects $2.4 million in net proceeds from the offering, which will close on April 8, 2019.
The company has lost 86% of its value in the trailing 52 weeks. For the year-to-date period, the stock is down 12%.
Meanwhile, ReWalk Robotics stock slipped 3% during the pre-market hours after the prosthetics firm said it would offer about 816,914 ordinary shares at a purchase price of $5.2025 apiece in a registered direct offering.
ReWalk will also issue unregistered warrants to buy about 408,457 ordinary shares, with a term of 5.5 years and exercise price of $5.14 per ordinary share.
The company, which makes wearable robotic exoskeletons for individuals with lower limb disabilities, expects gross proceeds of approximately $4.25 million. The offering is expected to close on April 8.
The stock is down 80% in the trailing 52 weeks. For the year-to-date period, the stock is up 6.2%.
Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!
As the coronavirus pandemic rages on, major retailers continue to experience huge demand for food and essential items both in their stores and online. Target Corporation (NYSE: TGT) is one
GameStop Corp. (NYSE: GME) swung to a profit in the fourth quarter of 2019 from a loss last year, helped by lower costs and expenses despite a 28% dip in
Footwear maker Skechers USA, Inc. (NYSE: SKX) lost considerable market value in recent weeks and under-performed the industry, amid growing fears that a recession is imminent. The crisis has left